Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TOMM6P1 is a *processed pseudogene* (a noncoding genomic DNA sequence derived from the mRNA of a functional gene, here the translocase of outer mitochondrial membrane 6 gene, TOMM6) and does not encode a functional protein. Pseudogenes are often transcriptionally inactive, but some may be transcribed into non-coding RNA with potential regulatory functions, such as serving as miRNA decoys or participating in RNA interference pathways to regulate the expression of their parent or related genes[1][3][4]. While some pseudogenes have been implicated in cancer or other diseases through these regulatory mechanisms, there is no direct evidence for any specific function or disease relevance for TOMM6P1. Summary interpretation: TOMM6P1 is a processed pseudogene, not a functional gene, receptor, or therapeutic target. It may have latent regulatory roles typical of pseudogenes, but no direct function or disease link has been described for it specifically. No therapies, biomarkers, or safety issues are associated with it. If a therapeutic target is required, information for TOMM6 (the protein-coding parent gene) should be used instead[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Translocase of outer mitochondrial membrane 6 homolog pseudogene 1 (TOMM6P1).